Figure 2.
Urinary IP-10 decreases with remission in LN. (A) LN patient serum IP-10 levels from an active disease collection date compared to an inactive (remission) disease collection date; (B) urine levels of IP-10 of active and remission samples available from the same patient and collection dates as 2A (n = 18; Two-Tailed Ratio T-Test). Patients with an increase in urine IP-10 during remission are highlighted in red and labelled with the patient number that correlates to Table 2.
